Benzoylpro-3 3 % Shampoo is a Health Canada–registered veterinary drug (DIN 02231809) held by Can-Vet Animal Health Supplies Ltd., containing Benzoyl Peroxide. Health Canada lists its status as Marketed (status date 01 Dec 2021). Nexara Health has matched 358 registrations of Benzoyl Peroxide across 17 other regulated markets.
Health Canada registration
| DIN | 02231809 |
|---|---|
| Brand name | Benzoylpro-3 |
| Active ingredient | Benzoyl Peroxide |
| Strength | 3 % |
| Dosage form | Shampoo |
| Route | Topical |
| Company | Can-Vet Animal Health Supplies Ltd. |
| Status | Marketed — 01 Dec 2021 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Benzoyl Peroxide registered in other markets
358 registrations of the same molecule in 17 national registries outside Canada (first 64 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Benzaknen 10 % Gel | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Benzaknen 5 % Gel | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Benzaknen 5 % Susp. zum Auftragen | — | 50ml | green box | eEKO (Erstattungskodex) | |
| Bahrain | Benzac Ac | Galderma International, France. | 5 % | Gel | POM | NHRA |
| Bahrain | Benzac Ac | Galderma International, France. | 2.5 % | Gel | POM | NHRA |
| Bulgaria | Acne Out BP | Биотрейд България ООД | 5% gel | гел | Без лекарско предписание | BDA |
| Czech Republic | Akneroxid | — | 50MG/G | Gel | R | SUKL DLP |
| Czech Republic | Akneroxid | — | 100MG/G | Gel | R | SUKL DLP |
| Hong Kong | Benzac Ac 10 Gel 10% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Benzac Ac 2 1/2 Gel 2.5% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Benzac Ac 5 Gel 5% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Benzac Ac Wash 5% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Bluecross Benzoyl Peroxide Acne Gel 5% W/W | Noble Health Co., Ltd | Registered | DH Drug Office | ||
| Hong Kong | Oxy Cover Cream 10% Maximum Strength | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Hong Kong | Oxy-10 Lotion 10% | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Hong Kong | Oxy-5 Lotion 5% | Mentholatum (Asia Pacific) Limited | Registered | DH Drug Office | ||
| Iceland | Basiron AC | Parlogis - óskráð lyf | 5 % | hlaup | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Acnecide 5% w/w Gel | Galderma International | Gel | Marketed | HPRA | |
| Ireland | Acnecide Wash 5 % w/w Gel | Galderma International | Gel | Marketed | HPRA | |
| Ireland | Brevoxyl 40 mg/g cream | Avianta Pharma EU Limited | Cream | Not marketed | HPRA | |
| Luxembourg | AKNEROXID GEL 100 mg / 1 g 1*1 GEL 50 G | — | P | CNS liste positive | ||
| Luxembourg | AKNEROXID GEL 50 mg / 1 g 1*1 GEL 50 G | — | P | CNS liste positive | ||
| Luxembourg | BENZAC-10 GEL 100 mg / 1 mL 1*1 GEL 40 G | — | P | CNS liste positive | ||
| Luxembourg | BENZAC-5 GEL 50 mg / 1 mL 1*1 tube 40 g | — | P | CNS liste positive | ||
| Malaysia | Benzac Ac 5% Gel | Galderma Malaysia Sdn Bhd | Non Prescription | PRODUCT APPROVED | NPRA | |
| Netherlands | Benzac 100 mg/ml, gel | Galderma Benelux B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Benzac 50 mg/ml, gel | Galderma Benelux B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Benzoylperoxide Teva 100 mg/g, hydrogel | Teva Nederland B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Benzoylperoxide Teva 50 mg/g, hydrogel | Teva Nederland B.V. | Gel | Uitsluitend apotheek of drogist | EU national register | |
| Poland | Akneroxid 10 | Almirall Hermal GmbH | 100 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Akneroxid 5 | Almirall Hermal GmbH | 50 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Benzacne | Orifarm Healthcare A/S | 50 mg/g | Żel | Bezterminowe | URPL RPL |
| Poland | Benzacne | Orifarm Healthcare A/S | 100 mg/g | Żel | Bezterminowe | URPL RPL |
| Saudi Arabia | Acnezoyl 2.5 % Gel | — | 2.5 | Inactive | SFDA | |
| Saudi Arabia | Acnezoyl 5% Gel | — | 5 | Inactive | SFDA | |
| Saudi Arabia | Panoxyl 10 Acne Gel | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Panoxyl 5 Lotion | — | 5 | Inactive | SFDA | |
| Taiwan | 080 Middle Antiacne Cream | 澳斯麗國際股份有限公司淡水廠 | 乳膏劑 | Registered | TFDA | |
| Taiwan | 10-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 10-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 10-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 5-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 5-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | 5-Benzagel | Dermik Lab. Inc. | 外用凝膠劑 | 已註銷 | TFDA | |
| Taiwan | A.d.f. Cream 5% "D.s" (Benzoyl Peroxide) | 臺灣派頓化學製藥股份有限公司岡山廠 | 軟膏劑 | Registered | TFDA | |
| Turkey | Triakne %5 Emulsiyojel 50 g | Orva İlaç San. Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| United Arab Emirates | Benzac AC ® 2.5% | LABORATOIRES GALDERMA, France, Alby Sur Cheran | 2½% | Gel | Active | EDE |
| United Arab Emirates | Benzac AC ® 5% | LABORATOIRES GALDERMA, France, Alby Sur Cheran | 5% | Gel | Active | EDE |
| United Kingdom | Benzoyl peroxide 10% / Potassium hydroxyquinoline sulfate 0.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 10% gel | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 10% lotion | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 10% wash | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 2.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 2.5% gel | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 3% / Clindamycin 1% gel | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Benzoyl peroxide 4% cream | — | 0001 | NHS dm+d VMP | ||
| United States | 10 Acne Med | Face Reality, Inc. | Gel | listed | FDA NDC | |
| United States | 111 Medco Benzoyl Peroxide | 111 Medco | Soap | listed | FDA NDC | |
| United States | 2.5 Acne Med | Face Reality, Inc. | Gel | listed | FDA NDC | |
| United States | 24 Hour Acne Serum | Drmtlgy, LLC | Gel | listed | FDA NDC | |
| United States | 5 Acne Med | Face Reality, Inc. | Gel | FDA NDC | ||
| United States | 5 Percent Benzoyl Peroxide Cleanser | Brand Evangelists for Beauty Limited | Gel | listed | FDA NDC | |
| United States | Acne Cleanser | Walmart, Inc. | Cream | listed | FDA NDC | |
| United States | Acne Cleanser | Meijer, Inc. | Cream | listed | FDA NDC |
See every manufacturer of Benzoyl Peroxide worldwide →
Regulator price references for Benzoyl Peroxide
Published list or reimbursement prices for Benzoyl Peroxide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Benzaknen 5 % Gel | 30000mg | 30g | 3.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Benzaknen 10 % Gel | 30000mg | 30g | 4.30 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Benzaknen 5 % Susp. zum Auftragen | 50ml | 50ml | 5.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Benzac Ac | 2.5pct | 60G | 1.23 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Benzac Ac | 5pct | 60G | 1.72 BHD | retail (max) | NHRA | 2026-09-01 |
| Iceland | Basiron AC | 5pct | túpa | 1,513.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Luxembourg | AKNEROXID GEL 50 mg / 1 g 1*1 GEL 50 G | 50mg/1000mg | 6.75 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | AKNEROXID GEL 100 mg / 1 g 1*1 GEL 50 G | 100mg/1000mg | 7.57 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | BENZAC-5 GEL 50 mg / 1 mL 1*1 tube 40 g | 50mg/1ml | 8.68 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | BENZAC-10 GEL 100 mg / 1 mL 1*1 GEL 40 G | 100mg/1ml | 9.24 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Saudi Arabia | Acnezoyl 2.5 % Gel | 2.5pct | 4.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Acnezoyl 5% Gel | 5pct | 8.30 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Panoxyl 5 Lotion | 10.40 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Panoxyl 10 Acne Gel | 14.70 SAR | public | SFDA | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Benzoylpro-3 (DIN 02231809) marketed in Canada?
Yes. Health Canada lists DIN 02231809 as Marketed as of 01 Dec 2021.
Who holds the Canadian licence for this product?
Can-Vet Animal Health Supplies Ltd. is the company of record in the Health Canada Drug Product Database.
Is Benzoyl Peroxide registered outside Canada?
Yes — Nexara Health has matched 358 registrations in 17 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02231809, status date 2021-12-01; national medicine registries: BDA, CNS liste positive, DH Drug Office, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02231809, status date 2021-12-01; national medicine registries: BDA, CNS liste positive, DH Drug Office, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NHRA, SFDA.
Health Canada Drug Product Database (DPD), DIN 02231809, status date 2021-12-01; national medicine registries: BDA, CNS liste positive, DH Drug Office, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, Lyfjastofnun lyfjaverdskra, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.